All sponsors

Italfarmaco

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING4
READOUTS ≤12 MONTHS1
Open Italfarmaco on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
GIV-IN-PV
NCT06093672
P3RecruitingPolycythemia Vera2202026-07
givinostat
NCT01761968
P2Active, not recruitingChronic Myeloproliferative Neoplasms902026-12
ULYSSES
NCT05933057
P3RecruitingDuchenne Muscular Dystrophy1382028-02 (+2 mo)
Givinostat Hydrochloride
NCT06769633
P2RecruitingDuchenne Muscular Dystrophy182029-12
Givinostat
NCT03373968
P2/3RecruitingDuchenne Muscular Dystrophy2062029-12 (+72 mo)